Liraglutide and oral semaglutide are also part of this class
Global Reach and Expanding Indications Though currently approved for type 2 diabetes, Tirzepatide is undergoing additional studies for obesity treatment in non-diabetic individuals, as well as cardiovascular outcome trials
The compound has an affinity to skin cells and supports natural collagen and elastin production, which helps to maintain firmness and an even complexion
This product is made with fiberglass material, therefore it will exhibit chips, breaks, cracks, waves, scratches and holes which require modification
Tirzepatide: Dual GLP-1 and GIP Agonist Independent of Weight Loss Tirzepatide, a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) agonist, has demonstrated efficacy in improving insulin action and reducing hepatic glucagon action in diet-induced obese mice